Arvin Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$21.7M |
| 2 |
Danaher
DHR
|
+$16.5M |
| 3 |
Pinterest
PINS
|
+$14.9M |
| 4 |
Avantor
AVTR
|
+$13.5M |
| 5 |
GXO Logistics
GXO
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$17.1M |
| 2 |
Carpenter Technology
CRS
|
+$13.8M |
| 3 |
Tower Semiconductor
TSEM
|
+$12.4M |
| 4 |
Adobe
ADBE
|
+$12.2M |
| 5 |
EPAM Systems
EPAM
|
+$11.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.3% |
| 2 | Industrials | 22.82% |
| 3 | Healthcare | 20.01% |
| 4 | Technology | 10.14% |
| 5 | Utilities | 8.63% |
Similar funds
Arvin Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Arvin Capital Management held 63 positions worth $488M, down 2.5% from $501M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Arvin Capital Management deployed $32.1M of net new capital in Q2 2025, opening 17 new positions and adding to 8 existing holdings. Its largest new stake was Thermo Fisher Scientific: 51,967 shares worth $21.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 46% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Carpenter Technology, an estimated $13.8M trimmed.
- Arvin Capital Management's largest Q2 2025 buy was Thermo Fisher Scientific: 51,967 shares worth $21.1M.
- Arvin Capital Management added most to Danaher in Q2 2025, an estimated $16.5M increase.
- Arvin Capital Management's biggest Q2 2025 reduction was Carpenter Technology, cutting an estimated $13.8M.
- Arvin Capital Management fully exited JD.com in Q2 2025, selling an estimated $17.1M.
- Arvin Capital Management's ten largest holdings make up 51% of its $488M portfolio in Q2 2025.
- Arvin Capital Management opened 17 new positions and closed 23 in Q2 2025.
- Arvin Capital Management's portfolio value fell 2.5% quarter-over-quarter to $488M.
Based on Arvin Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.